Treace Medical Concepts, Inc.
Jaime Frias has a diverse work experience spanning over several decades. Currently, they serve as the Chief Business Development Officer at Treace Medical Concepts, Inc. Prior to this role, they held positions such as Chief Legal and Compliance Officer, Secretary at Treace Medical Concepts, Inc. and VP, General Counsel, Secretary, and Chief Compliance Officer at the same company.
Before joining Treace Medical Concepts, Inc., Jaime was the owner and president of Frias Legal PA, where they worked from 2014 to 2021. Jaime also had a significant tenure at Medtronic, where they held roles including Vice President, Chief Legal Counsel, Medtronic Surgical Technologies and VP, Senior Legal Counsel.
Earlier in their career, Jaime worked as General Counsel at Xomed Surgical Products and had a brief stint as a Partner at McGuire Woods. Jaime began their professional journey as an Associate at Baker & McKenzie.
Overall, Jaime Frias has extensive experience in legal and compliance roles, demonstrating their expertise and leadership in the medical industry.
Jaime Frias began their education in 1979 at the University of Florida, where they pursued a Bachelor of Arts degree in Music with a focus on Piano Performance and Composition. Their studies lasted from 1979 to 1983. Following this, they enrolled at Florida State University in 1983 to pursue Graduate Studies in Music, specifically Piano Performance and Composition. Their time at Florida State University ended in 1984.
In 1984, Jaime Frias continued their Graduate Studies at the University of Florida, furthering their knowledge in Music and Creative Writing. This program lasted from 1984 to 1985. Subsequently, they went on to attend the University of Michigan Law School in 1985, where they completed their Juris Doctor (JD) degree in Law. This program lasted from 1985 to 1988.
This person is not in any offices
Treace Medical Concepts, Inc.
1 followers
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans1, of which Treace estimates 1.1 million are annual surgical candidates. Treace Medical has pioneered and patented the Lapiplasty® 3D Bunion Correction™ system – a combination of instruments, implants, and surgical methods designed to surgically correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause2,3 of the bunion and helping patients get back to their active lifestyles. Treace Medical has expanded its offering with the Adductoplasty™ Midfoot Correction System, designed for reproducible surgical correction of the midfoot to provide further support to hallux valgus patients. For more information, please visit www.treace.com. The content herein is for informational purposes and intended for healthcare professionals only. Treace Medical Concepts, Inc. does not dispense medical advice. A surgeon should rely on his or her own professional clinical judgment when deciding whether to use a specific product when treating a particular patient. Prior to use of the device, the surgeon should refer to the instructions for use for complete indications, contraindications, warnings, and risks. For complete risk and benefit information, visit Treace.com. **Please note** Treace Medical will make an offer of employment only to individuals who have applied for a position using our official application. Be on alert for possible fraudulent offers of employment. Treace Medical will not solicit money or banking information from applicants. 1Nix S, et al. J Foot Ankle Res. 2010. 27:3:21. 2Dayton P, et al. J Foot Ankle Surg. 2016;55:567-71. 3Dayton P, et al. J Foot Ankle Surg. 2018;57:766-770.